About GCCL

With an exclusive lab service available for clinical trials and a logistics system that meets global quality standards,
GCCL is building trust with over 200 partners in Asia by providing a sample analysis service spanning
the entire cycle of clinical trials to meet customer demands.

Company News

홈   >   About GCCL   >   Newsroom   >   Company News

2025. 02. 05

GCCL Wins the 2025 Best Practices Customer Value Leadership Award from Frost & Sullivan

Today, we are excited to share the news that GCCL has been honored with the 2025 Best Practices Customer Value Leadership Award from Frost & Sullivan, recognizing excellence in the Asia Pacific (APAC) clinical sample analysis services industry.About the Frost & Sullivan Best Practices AwardsFrost & Sullivan is a global market research firm with over 60 years of history, recognizing companies that achieve growth through innovative services.The Best Practices Customer Value Leadership Award is presented only to companies that deliver outstanding value to their customers. The selection process involves rigorous evaluations based on multiple criteria, including Growth Potential, Customer Acquisition, Customer Experience, Operational Efficiency, and Brand Equity. After multiple rounds of assessments, GCCL was recognized as a leader in clinical sample analysis services.GCCL: A One-Stop Lab Solution for Clinical TrialsAt GCCL, we operate an integrated Central Lab, Bioanalytical Lab, and BL3 (Biosafety Level 3) facility, allowing us to:✅ Minimize sample movement, reducing costs and turnaround time✅ Enhance data reliability, ensuring high-quality results✅ Provide optimal analytical solutions, supporting successful drug developmentBeyond APAC, we collaborate with global partners to ensure compliance with FDA, EMA, and other major regulatory standards, delivering world-class clinical sample analysis services.In 2024, we established a dedicated R&D Unit and introduced cutting-edge platforms such as ddPCR and a global Laboratory Information Management System (LIMS) to provide more efficient and precise services tailored to our clients’ needs.Why Frost & Sullivan Recognized GCCLFrost & Sullivan highlighted GCCL’s strong internal capabilities, commitment to global quality standards, and continuous service enhancements as key factors in leading the APAC clinical sample analysis market. The following strengths set us apart:✅ All-in-One Clinical Trial LabUnlike other global central labs that often outsource services to different countries, GCCL integrates all essential lab functions within South Korea. This ensures:✔ Faster turnaround times✔ Greater sample stability✔ Seamless, high-quality data analysis✅ Tailored Solutions & Rapid Sample ProcessingWe provide customized analytical services based on client needs. Notably, our PBMC sample processing time is under 8 hours—more than 3 times faster than global labs, significantly improving efficiency for drug developers.✅ Advanced Technology & AutomationWe leverage state-of-the-art technologies such as:✔ BIO-RAD Evolis System – Ensuring consistent and automated bioanalytical testing✔ Droplet Digital PCR (ddPCR) – Enhancing precision in sample analysis✔ G-HUB Platform– Optimizing real-time sample tracking and data management✅ Customer-Centric ApproachGCCL goes beyond standard sample analysis, fostering close collaboration with clients to support their clinical research success.In our 2024 customer satisfaction survey, GCCL received outstanding ratings, reinforcing our reputation as a trusted industry partner.Read the Full Award ReportFor more details on the award, please refer to the official report: 🔗 Frost & Sullivan 2025 GCCL Award ReportLooking AheadThis award is not just an achievement—it is a testament to the trust and technological excellence GCCL has built through our customer-first approach.As a leading central lab in APAC, we are committed to expanding our global presence and delivering even greater value to pharmaceutical and biotech partners worldwide.Moving forward, we will continue to enhance our services, collaborate with global drug developers, and drive innovation in clinical sample analysis.Stay tuned as GCCL continues to push the boundaries of clinical research, supporting successful drug development worldwide. 🚀

Read more